Updated
Twelve companies, including Health In Tech, HubSpot, Avalyn Pharma, MeiraGTx, Profound Medical, Prime Medicine, Western Union, Lucid Diagnostics, Aktis Oncology, Cohen & Co, Starling Oncology and Kyverna Therapeutics, filed Form 8-K current reports with the SEC on November 12, 2026, according to EDGAR listings. The listings show only filer names and no filing contents, so the reasons for the filings are not known. No financial impact or market reaction was reported for any of the filings. Form 8-K reports are used to disclose material events, and the listings do not indicate which events prompted these disclosures.